30.92
price up icon0.10%   0.03
after-market 시간 외 거래: 31.50 0.58 +1.88%
loading
전일 마감가:
$30.89
열려 있는:
$31.61
하루 거래량:
598.88K
Relative Volume:
0.82
시가총액:
$3.09B
수익:
$266.72M
순이익/손실:
$-334.62M
주가수익비율:
-7.5415
EPS:
-4.1
순현금흐름:
$-206.67M
1주 성능:
-1.62%
1개월 성능:
+17.30%
6개월 성능:
+90.28%
1년 성능:
+20.22%
1일 변동 폭
Value
$30.62
$31.61
1주일 범위
Value
$30.01
$31.66
52주 변동 폭
Value
$13.48
$36.60

Zai Lab Limited Adr Stock (ZLAB) Company Profile

Name
명칭
Zai Lab Limited Adr
Name
전화
862161632588
Name
주소
4560 JINKE ROAD, SHANGHAI
Name
직원
2,175
Name
트위터
Name
다음 수익 날짜
2024-11-12
Name
최신 SEC 제출 서류
Name
ZLAB's Discussions on Twitter

Zai Lab Limited Adr Stock (ZLAB) Upgrades & Downgrades

날짜 액션 분석자 등급 변경
2023-12-14 개시 Morgan Stanley Overweight
2023-08-10 개시 Cantor Fitzgerald Overweight
2022-01-21 개시 Macquarie Outperform
2021-10-12 개시 Bernstein Mkt Perform
2020-04-28 개시 Goldman Buy
2020-04-15 개시 Guggenheim Buy
2019-07-12 개시 BofA/Merrill Buy
2019-07-05 개시 Macquarie Outperform
2019-01-29 개시 Credit Suisse Outperform
2018-11-21 개시 Jefferies Buy
2018-06-21 재개 Leerink Partners Outperform
2018-02-14 업그레이드 JP Morgan Neutral → Overweight
2017-10-16 개시 JP Morgan Neutral
2017-10-16 개시 Leerink Partners Outperform
모두보기

Zai Lab Limited Adr 주식(ZLAB)의 최신 뉴스

pulisher
03:45 AM

Zai Lab Limited (NASDAQ:ZLAB) Holdings Trimmed by Mirae Asset Global Investments Co. Ltd. - MarketBeat

03:45 AM
pulisher
Nov 04, 2024

JP Morgan analysts reiterates an Overweight rating for Roku Inc (ROKU) - Knox Daily

Nov 04, 2024
pulisher
Oct 29, 2024

Zai Lab Reports Positive Topline Data from Phase 3 Bridging Trial Evaluating KarXT for the Treatment of Schizophrenia in China - Business Wire

Oct 29, 2024
pulisher
Oct 27, 2024

Zai Lab (NASDAQ:ZLAB) Stock Price Down 3.7% – Here’s What Happened - Defense World

Oct 27, 2024
pulisher
Oct 26, 2024

Zai Lab Limited (ZLAB) Moves 14.7% Higher: Will This Strength Last? - MSN

Oct 26, 2024
pulisher
Oct 25, 2024

Biopharma operator Zai Lab surges to 16-month high on lung cancer drug trial results - Mugglehead

Oct 25, 2024
pulisher
Oct 25, 2024

Trial highlights potential next-gen biologic for lung cancer - Marketscreener.com

Oct 25, 2024
pulisher
Oct 25, 2024

Zai Lab (NASDAQ:ZLAB) Receives Overweight Rating from Cantor Fitzgerald - MarketBeat

Oct 25, 2024
pulisher
Oct 25, 2024

Zai Lab (NASDAQ:ZLAB) Shares Down 3.7%What's Next? - MarketBeat

Oct 25, 2024
pulisher
Oct 25, 2024

Hennion & Walsh Asset Management Inc. Boosts Stake in Zai Lab Limited (NASDAQ:ZLAB) - MarketBeat

Oct 25, 2024
pulisher
Oct 25, 2024

Zai Lab stock soars to 52-week high, touches $32.5 - Investing.com India

Oct 25, 2024
pulisher
Oct 24, 2024

Citi raises Zai Lab target on promising trial results - Investing.com

Oct 24, 2024
pulisher
Oct 24, 2024

This Biotech Leader Just Hit A 16-Month High On An 'Impressive' Test - Investor's Business Daily

Oct 24, 2024
pulisher
Oct 24, 2024

Zai Lab (NASDAQ:ZLAB) Hits New 12-Month HighHere's What Happened - MarketBeat

Oct 24, 2024
pulisher
Oct 24, 2024

ZL-1310, an Investigational DLL3-Targeted Antibody-Drug Conjugate (ADC), Demonstrates Promising Objective Response Rates and Safety Profile in Extensive-Stage Small Cell Lung Cancer - BioSpace

Oct 24, 2024
pulisher
Oct 21, 2024

Zai Lab Announces Participation in November and December Investor Conferences - BioSpace

Oct 21, 2024
pulisher
Oct 21, 2024

JPMorgan Chase & Co. Raises Zai Lab (NASDAQ:ZLAB) Price Target to $44.00 - MarketBeat

Oct 21, 2024
pulisher
Oct 20, 2024

Zai Lab (NASDAQ:ZLAB) Shares Up 6.5% – Still a Buy? - Defense World

Oct 20, 2024
pulisher
Oct 18, 2024

Zai Lab (NASDAQ:ZLAB) Stock Price Up 6.5%Here's What Happened - MarketBeat

Oct 18, 2024
pulisher
Oct 17, 2024

Zai Lab to Host Webcast Presentation to Discuss Data from Early Clinical Program Evaluating Its Investigational DLL3-Targeted Antibody-Drug Conjugate (ADC) ZL-1310 - Business Wire

Oct 17, 2024
pulisher
Oct 16, 2024

Zai Lab (NASDAQ:ZLAB) Shares Gap UpShould You Buy? - MarketBeat

Oct 16, 2024
pulisher
Oct 16, 2024

Zai Lab to Announce Third Quarter 2024 Financial Results and Recent Corporate Updates on November 12, 2024 - BioSpace

Oct 16, 2024
pulisher
Oct 15, 2024

Dimensional Fund Advisors LP Acquires New Shares in Zai Lab Limited (NASDAQ:ZLAB) - Defense World

Oct 15, 2024
pulisher
Oct 15, 2024

An Analysis of Zai Lab Limited ADR (ZLAB)’s Potential Price Growth - Knox Daily

Oct 15, 2024
pulisher
Oct 15, 2024

Recent Insider Activity Could Benefit Booz Allen Hamilton Holding Corp (BAH) - Knox Daily

Oct 15, 2024
pulisher
Oct 15, 2024

Examining the Potential Price Growth of Phillips 66 (PSX) - Knox Daily

Oct 15, 2024
pulisher
Oct 15, 2024

Verona Pharma Plc ADR [VRNA] Insider Activity: An Update for Investors - Knox Daily

Oct 15, 2024
pulisher
Oct 15, 2024

Analyzing First Solar Inc (FSLR) After Recent Trading Activity - Knox Daily

Oct 15, 2024
pulisher
Oct 15, 2024

Phathom Pharmaceuticals Inc [PHAT] Investment Appeal on the Rise - Knox Daily

Oct 15, 2024
pulisher
Oct 15, 2024

Ratios in Focus: Analyzing Zai Lab Limited ADR (ZLAB)’s Price-to-Cash and Price-to-Free Cash Flow - The Dwinnex

Oct 15, 2024
pulisher
Oct 15, 2024

Zai Lab Limited ADR (ZLAB)’s stock chart: A technical perspective - US Post News

Oct 15, 2024
pulisher
Oct 14, 2024

Zai Lab (NASDAQ:ZLAB) Stock Price Down 3.2%What's Next? - MarketBeat

Oct 14, 2024
pulisher
Oct 10, 2024

Zai Lab Limited (NASDAQ:ZLAB) Shares Acquired by Renaissance Technologies LLC - Defense World

Oct 10, 2024
pulisher
Oct 10, 2024

MASI Stock Sees Surge of Approximately 5.87% in Last Five Days - Knox Daily

Oct 10, 2024
pulisher
Oct 10, 2024

DENTSPLY Sirona Inc [XRAY] Director makes an insider acquire of 8,212 shares worth 199,983. - Knox Daily

Oct 10, 2024
pulisher
Oct 10, 2024

Zai Lab Limited ADR [ZLAB] Shares Fall -0.81 % on Wednesday - Knox Daily

Oct 10, 2024
pulisher
Oct 10, 2024

SPWH Shares Experience Decline in Value - Knox Daily

Oct 10, 2024
pulisher
Oct 09, 2024

Upward Trajectory: Zai Lab Limited ADR (ZLAB) Posts a Slidee, Closing at 24.84 - The Dwinnex

Oct 09, 2024
pulisher
Oct 09, 2024

Zai Lab Limited ADR’s Bumpy Road: Analyzing the 52-Week Range and Future Prospects - The InvestChronicle

Oct 09, 2024
pulisher
Oct 09, 2024

ZLABZai Lab Limited American Depositary Shares Latest Stock News & Market Updates - StockTitan

Oct 09, 2024
pulisher
Oct 09, 2024

A look into Zai Lab Limited ADR (ZLAB)’s deeper side - SETE News

Oct 09, 2024
pulisher
Oct 09, 2024

Zai Lab to Present Data from Phase 1 Trial of ZL-1310, Its Investigational Antibody-Drug Conjugate (ADC) for DLL3+ Solid Tumors, at EORTC-NCI-AACR Symposium (ENA) 2024 - BioSpace

Oct 09, 2024
pulisher
Oct 08, 2024

Zai Lab (NASDAQ:ZLAB) Shares Gap Down – Here’s What Happened - Defense World

Oct 08, 2024
pulisher
Oct 08, 2024

Zai Lab (NASDAQ:ZLAB) Shares Gap DownHere's Why - MarketBeat

Oct 08, 2024
pulisher
Oct 08, 2024

Zai Lab Limited ADR (ZLAB) deserves closer scrutiny - US Post News

Oct 08, 2024
pulisher
Oct 07, 2024

The Potential Rise in the Price of Weyerhaeuser Co. (WY) following insiders activity - Knox Daily

Oct 07, 2024
pulisher
Oct 07, 2024

Insider Sale Alert: BlackSky Technology Inc [BKSY] – Is it Time to sell? - Knox Daily

Oct 07, 2024
pulisher
Oct 07, 2024

Zai Lab Limited ADR [ZLAB] Stock sold by Insider Chen Yajing for $7645.0 - Knox Daily

Oct 07, 2024
pulisher
Oct 07, 2024

Checking in on Dutch Bros Inc (BROS) after recent insiders movement - Knox Daily

Oct 07, 2024
pulisher
Oct 07, 2024

Investing in Shattuck Labs Inc (STTK) Is Getting More Attractive - Knox Daily

Oct 07, 2024
pulisher
Oct 07, 2024

Zai Lab (NASDAQ:ZLAB) Shares Gap Up – Here’s What Happened - Defense World

Oct 07, 2024

Zai Lab Limited Adr (ZLAB) 재무 분석

매출

loading

순이익

loading

현금흐름

loading

주당 순 이익

loading

Zai Lab Limited Adr 주식 (ZLAB) 내부자 거래

내부자 거래 관계 날짜 거래 비용 #주식 가치 ($) #주식 총계
Chen Yajing
Chief Financial Officer
Oct 02 '24
Sale
25.40
301
7,645
15,161
$77.28
price up icon 2.02%
$20.39
price up icon 2.15%
$382.77
price up icon 1.58%
$53.29
price down icon 0.47%
$208.03
price up icon 0.38%
$110.97
price up icon 1.84%
자본화:     |  볼륨(24시간):